An update on the Scianna blood group system.


Journal

Immunohematology
ISSN: 0894-203X
Titre abrégé: Immunohematology
Pays: United States
ID NLM: 8806387

Informations de publication

Date de publication:
Jun 2019
Historique:
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 10 7 2019
Statut: ppublish

Résumé

This update of the Scianna blood group system (Brunker PA, Flegel WA. Scianna: the lucky 13th blood group system. Immunohematology 2011;27:41-57) provides the recent work on the genetic variation of ERMAP across more world populations, the elucidation of the molecular basis of an historical serologic case, new cases of antibodies in the system, the development of new serologic reagents, and new discoveries in the biology of the erythroid membrane associated protein (ERMAP). Although genetic variation in ERMAP has been extensively cataloged, nonsynonymous variants associated with alloantigens have remained limited, and no new antigens have been identified. The first case of a severe hemolytic transfusion reaction to anti-Sc2 has recently been reported, highlighting the importance of pursuing the possibility of antibodies to low-prevalence antigens via indirect antiglobulin testing as a routine component of all transfusion reaction investigations. The expanding use of molecular testing in blood centers and transfusion services has uncovered a wider population distribution of Scianna antigens and heightened the awareness of this blood group system. The International Society of Blood Transfusion recognizes seven antigens in the Scianna blood group system 13.

Identifiants

pubmed: 31246487
pmc: PMC6684214
mid: NIHMS1035898

Substances chimiques

Blood Group Antigens 0
Isoantigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-50

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CL999999
Pays : United States

Références

Transfusion. 2009 Oct;49(10):2090-6
pubmed: 19555420
Blood. 2011 Aug 25;118(8):2044-54
pubmed: 21613252
Immunohematology. 2011;27(2):41-57
pubmed: 22356519
Blood. 2013 May 30;121(22):4575-85
pubmed: 23610375
Immunohematology. 2013;29(2):69-72
pubmed: 24094239
Blood. 2015 Apr 9;125(15):2405-17
pubmed: 25724378
Annu Rev Immunol. 2016 May 20;34:151-72
pubmed: 26772212
Transfusion. 2016 Dec;56(12):3047-3054
pubmed: 27612015
Transfusion. 2017 Jun;57(6):1485-1487
pubmed: 28267201
Blood Adv. 2016 Dec 16;1(3):240-249
pubmed: 29296939
Transfus Med Rev. 2019 Jan;33(1):24-28
pubmed: 30139679
Transfusion. 2018 Nov;58(11):2506-2512
pubmed: 30299537
Transfusion. 2018 Nov;58(11):2693-2704
pubmed: 30312480
Vox Sang. 2019 Jan;114(1):95-102
pubmed: 30421425
Immunohematology. 2019 Jan;35(1):19-22
pubmed: 30908075
Transfusion. 1967 Sep-Oct;7(5):336-42
pubmed: 6069618

Auteurs

Patricia A R Brunker (PAR)

Medical Director, American Red Cross, Biomedical Services, Greater Chesapeake and Potomac Region.

Willy A Flegel (WA)

Chief, Laboratory Services Section, DTM/CC/NIH, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH